**Author details**

**Acknowledgements**

112 Towards Malaria Elimination - A Leap Forward

transmission in selected settings.

**Conflict of interest**

**List of acronyms**

The authors would like to specifically thank Sergio Lopes and Allan Schapira for their comments and inputs to the manuscript. We thank Irwin Chavez for supporting EndNote citations and references. The authors thank WHO for approval to reproduce **Figures 1** and **2** taken from [2]. Data for Thailand and Vietnam in **Table 1** was supported by the Special Programme for Research and Training in Tropical Diseases (TDR), in partnership with the Global Malaria Programme of the World Health Organisation (WHO) to develop multi-country, multi-institutional research on Investigation of the magnitude and causes of residual malaria parasite

All authors declare no conflict of interest related to the writing of this chapter.

ACT Artemisinin-based combination therapy

ASEAN Association of Southeast Asian nations

BCC Behavioral change communication

EIR Entomological inoculation rate

FDA Food and drug administration

GMS Greater Mekong Subregion

LLIN Long lasting insecticidal nets

LSM Larval source management

IRS Indoor residual spraying

ITN Insecticide treated nets

ELISA Enzyme-linked immunosorbent assay

G6PD Glucose-6-phosphate dehydrogenase

LLIHN Long lasting insecticidal hammock nets

ERAR Emergency response to artemisinin resistance

AMT Artemisinin monotherapy

DNA Deoxyribonucleic acid

CSP Circumsporozoite

Jeffrey Hii<sup>1</sup> , Indra Vythilingam<sup>2</sup> and Arantxa Roca-Feltrer<sup>3</sup> \*

\*Address all correspondence to: a.roca@malariaconsortium.org

1 Malaria Consortium Asia, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

2 University of Malaya, Kuala Lumpur, Malaysia

3 Malaria Consortium, London, United Kingdom
